Orthopaedic Care Partners (OCP) welcomes Rob Passaro as Vice President of Business Development. His appointment supports OCP’s ongoing growth initiatives, strengthens its market presence, and contributes to building long-term value with physician partners.
Passaro brings nearly twenty years of healthcare and business development expertise, having held leadership roles within high-growth, physician-led, and private equity-backed organisations. His experience includes corporate development, finance, operations, and strategy, with a track record of building sustainable partnerships and creating value. As Vice President of Business Development, Rob will collaborate closely with physicians and executive leaders to identify acquisition opportunities, develop a comprehensive growth pipeline, and support integration efforts that promote output across the platform.
“Rob is a proven leader in building and growing platforms that yield significant returns for long-term outcomes,” said Tim Corvino, MD, CEO of OCP. “He knows how to truly partner with physicians, expand thoughtfully and turn strategic opportunity into measurable results. As OCP increases its focus on growth as a critical driver over the next year, Rob brings the judgment, credibility, and execution needed to help elevate the platform and advance our next phase of expansion.”
Most recently, Passaro held senior positions at CityMD, Summit Health, and the merged CityMD–Summit–VillageMD platform, including SVP of Corporate Development, Chief of Staff to the CEO, and VP of Finance. He led national M&A and strategy teams, overseeing transactions across diverse healthcare segments, and contributed significantly to key milestones throughout the organisation’s expansion. Prior to that, Rob served as CFO of WIN Fertility, where he led financial and operational strategy.
“With clinical strength at its core, combined with the alignment between physicians and leadership, OCP is poised for significant expansion,” said Passaro. “I’m eager to bring my experiences and expertise to bear, supporting growth initiatives through disciplined execution that are physician-led, operationally sound, and designed to build a scalable platform with durable enterprise earnings over the long term.”
In his new capacity, Passaro will expand OCP’s presence in both established and emerging markets, enhance partnerships with physicians and health systems, and drive growth initiatives aligned with OCP’s core strategic priorities and vision. His appointment, in partnership with Rob Scoskie, who was recently named Chief Development Officer, underscores the company’s commitment to responsible, sustainable growth supported by strong leadership and robust infrastructure, with continued emphasis on clinical excellence and quality care.
More related news:
Helios Technologies Strengthens Finance and Accounting Leadership Team
DigniFi Appoints Andrew Hill as Chief Credit Risk Officer to Boost Risk Leadership
Ametros Strengthens Leadership to Improve Member Experience and Operations
